Johnson & Johnson: Trouble Behind?
Less than a month ago, I recommended buying shares of Johnson & Johnson (JNJ) after the stock had tumbled more than 3% in one day. At the time, I mentioned that the market seemed worried about the sluggish growth in Johnson & Johnson's pharmaceutical business. Shares of Johnson & Johnson have gained 3.2% since April 22, when I made the call, while the S&P 500 has risen 2.3%.
http://finance.yahoo.com/r/e4c27a64-...ahoo&.tsrc=rss
S&P500 (C Fund) (delayed) (Stockcharts.com Real-time) |
DWCPF (S Fund) (delayed) (Stockcharts.com Real-time) |
EFA (I Fund) (delayed) (Stockcharts.com Real-time) |
BND (F Fund) (delayed) (Stockcharts.com Real-time) |
||
Yahoo Finance Realtime TSP Fund Tracking Index Quotes |
Bookmarks